Literature DB >> 15461706

Acute renal failure: from renal physiology to the renal transcriptome.

Robert L Safirstein1.   

Abstract

Acute renal failure (ARF) is defined as an abrupt fall in glomerular filtration rate. Fully 5% of all patients admitted to the hospital undergo ARF with an attendant increase in morbidity and mortality. We have studied murine models of ischemia/reperfusion and cisplatin-induced renal failure in detail to determine the physiologic and molecular events that are responsible for the syndrome. Both forms of treatment induce necrosis of the proximal tubules, as well as more subtle changes in distal nephron viability, including apoptosis. Both forms are characterized by reduced renal blood, reduced glomerular filtration rate, and a urine-concentrating defect. Simultaneous with the onset of these morphologic and functional features is the commitment of cells to DNA synthesis and cell division, which is preceded by activation of signal transduction pathways and gene transcription that presumably underlie the morphologic and functional changes responsible for the syndrome. We describe a functional genomic approach using microarray data and available database searches to attempt to predict new targets for investigation of the pathogenesis and treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461706     DOI: 10.1111/j.1523-1755.2004.09110.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  14 in total

1.  Overexpression of cGMP-dependent protein kinase I (PKG-I) attenuates ischemia-reperfusion-induced kidney injury.

Authors:  Yanzhang Li; Xiaopeng Tong; Hasiyeti Maimaitiyiming; Kate Clemons; Ji-Min Cao; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia.

Authors:  Charuhas V Thakar; Kamyar Zahedi; Monica P Revelo; Zhaohui Wang; Charles E Burnham; Sharon Barone; Shannon Bevans; Alex B Lentsch; Hamid Rabb; Manoocher Soleimani
Journal:  J Clin Invest       Date:  2005-11-17       Impact factor: 14.808

3.  The influence of EPO and hypothermia on the kidneys of rats after perinatal asphyxia.

Authors:  Vesna Stojanović; Nada Vučković; Slobodan Spasojević; Nenad Barišić; Aleksandra Doronjski; Dragan Zikić
Journal:  Pediatr Nephrol       Date:  2011-07-02       Impact factor: 3.714

4.  Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses.

Authors:  Peter S T Yuen; Sang-Kyung Jo; Mikaela K Holly; Xuzhen Hu; Robert A Star
Journal:  Physiol Genomics       Date:  2006-02-28       Impact factor: 3.107

Review 5.  Pathophysiology of ischemic acute kidney injury.

Authors:  Asif A Sharfuddin; Bruce A Molitoris
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

Review 6.  Acute kidney injury: a springboard for progression in chronic kidney disease.

Authors:  Manjeri A Venkatachalam; Karen A Griffin; Rongpei Lan; Hui Geng; Pothana Saikumar; Anil K Bidani
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-03

Review 7.  Chronic kidney disease following acute kidney injury-risk and outcomes.

Authors:  Kelvin C W Leung; Marcello Tonelli; Matthew T James
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

8.  Apoptosis of the thick ascending limb results in acute kidney injury.

Authors:  Manakan B Srichai; Chuanming Hao; Linda Davis; Anastasia Golovin; Min Zhao; Gilbert Moeckel; Steve Dunn; Nada Bulus; Raymond C Harris; Roy Zent; Matthew D Breyer
Journal:  J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 10.121

Review 9.  Moving beyond supportive care--current status of specific therapies in pediatric acute kidney injury.

Authors:  Jordan M Symons
Journal:  Pediatr Nephrol       Date:  2013-02-14       Impact factor: 3.714

10.  Renalase prevents AKI independent of amine oxidase activity.

Authors:  Ling Wang; Heino Velazquez; Gilbert Moeckel; John Chang; Ahrom Ham; H Thomas Lee; Robert Safirstein; Gary V Desir
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.